In 2017, the value of the global cell therapy market was 5.22 billion US dollars (Grand View Research, 2018). The market value is expected to reach $ 7.92 billion in 2025, with a cumulative annual growth rate (CAGR) of 5.34 percent. The value of the gene therapy market in 2018 is $0.39 billion and has a CAGR of 33.9 percent. Currently, the market values of both markets are not high when compared to the ongoing growth of cells and gene therapy research. Meanwhile, the value of the world’s stem cell market, which is considered the upstream industry of cells and gene therapy industries, is 16.09 billion US dollars and is expected to reach $28.56 billion in 2023, with a CAGR of 10.04 percent.